Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC
Clinical trial NCT03769129 · RECRUITING
Trial details
- NCT number
- NCT03769129
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2026-11-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.